Dr. Charles DeCarli's study on brain conditions linked to dementia was abruptly terminated, highlighting issues with U.S. scientific funding. His $53 million research, involving 1,700 patients, aimed to deepen the understanding of Alzheimer's disease, now affecting 7 million Americans over 65. The study's cut, attributed to its focus on diversity and perceived non-compliance with current administration priorities, raises serious concerns about the future of Alzheimer's research, especially as the number of elderly patients is expected to nearly double in 35 years.
Dr. DeCarli articulated his frustration, stating, 'This was the culmination of my career, the pinnacle of my research over the last 38 years.'
The letter from NIH noted that the study was cut because it contained 'artificial and non-scientific categories' that did not align with current agency priorities.
With Alzheimerâs affecting over 7 million U.S. residents aged 65 and older, DeCarli argued, 'It doesnât make sense that understanding such complex brain diseases is no longer a priority.'
DeCarli points out, 'I suspect I was targeted because of the name of my study... DEI programs are on the administration's hit list.'
Collection
[
|
...
]